From July 1, 2023 to October 31, 2023, the company has repurchased 258,900 shares, representing 0.8% for CAD 1.63 million. With this, the company has completed the repurchase of 334,869 shares, representing 1.04% for CAD 2 million under the buyback announced on November 10, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.65 CAD | -1.69% | -6.06% | +17.72% |
Apr. 08 | HLS Therapeutics Inc. Announces Reduce-IT Analysis Results Relating the Effects of VASCEPA | CI |
Mar. 14 | Transcript : HLS Therapeutics Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.72% | 108M | |
+17.35% | 71.39B | |
+5.38% | 8.59B | |
+6.69% | 8.19B | |
-20.96% | 7.91B | |
+0.49% | 4.54B | |
+17.12% | 4.31B | |
-3.38% | 3.93B | |
-2.61% | 3.86B | |
+22.08% | 3.64B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- Tranche Update on HLS Therapeutics Inc.'s Equity Buyback Plan announced on November 10, 2022.